AP 115 Pill: white, capsule/oblong, 15mm
The pill with imprint AP 115 (White, Capsule/Oblong, 15mm) has been identified as Hyoscyamine Sulfate Extended Release 0.375 mg and is used for Diverticulitis, Anticholinesterase Poisoning, Irritable Bowel Syndrome, Anesthesia, and Neurogenic Bladder. It belongs to the drug class anticholinergics/antispasmodics and is not a controlled substance.
Images for AP 115
Hyoscyamine Sulfate Extended Release
- Imprint
- AP 115
- Strength
- 0.375 mg
- Color
- White
- Size
- 15.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Anticholinergics/antispasmodics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Franklin Pharmaceutical LLC
- Inactive Ingredients
-
calcium phosphate dihydrate dibasic,
lactose monohydrate,
ethylcellulose,
microcrystalline cellulose,
stearic acid,
magnesium stearate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 50532-0115 | Franklin Pharmaceutical LLC |
| 51525-0115 | Wallace Pharmaceuticals Inc. |
| 68220-0115 | Alaven Pharmaceuticals |
Related images for "AP 115"
More about hyoscyamine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (116)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: anticholinergics/antispasmodics
- En español
Patient resources
- Hyoscyamine drug information
- Hyoscyamine Extended-Release Tablets
- Hyoscyamine Orally Disintegrating Tablets
- Hyoscyamine Sublingual Tablets
- Hyoscyamine Tablets
Other brands
Levsin, Hyosyne, Oscimin, HyoMax, ... +5 more
Professional resources
- Hyoscyamine monograph
- Hyoscyamine Sulfate Elixir (FDA)
- Hyoscyamine Sulfate Extended-Release Tablets (FDA)
- Hyoscyamine Sulfate Injection (FDA)
- Hyoscyamine Sulfate Oral Drops (FDA)
Other brands
Levsin, Hyosyne, Levsin SL, Levbid, ... +6 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.